Novartis India Ratios

Novartis India Ltd Ratios

The Novartis India Ltd Ratios page provides a complete fundamental analysis of Novartis India Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Novartis India Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Novartis India Ltd (NSE: NOVARTIND, BSE: 500672) is currently trading at ₹2046.80, with a market capitalization of ₹5137.78Cr. As a major player in the Health technology sector and Pharmaceuticals: major industry, Novartis India Ltd remains a key stock for fundamental analysis using Novartis India Ltd Ratios.

Novartis India Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Novartis India Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Novartis India Ltd Ratios.

Historically, the Novartis India Ltd P/E ratio has shown strong fluctuations:

The decline in Novartis India Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Novartis India Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Novartis India Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Novartis India Ltd P/S ratio currently stands at 0, an important part of Novartis India Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Novartis India Ltd P/S ratio indicates cautious market sentiment.

Novartis India Ltd Price to Cash Flow Ratio (P/CF)

The Novartis India Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Novartis India Ltd Price to Cash Flow Ratio:

The declining Novartis India Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Novartis India Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Novartis India Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Novartis India Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Novartis India Ltd EV/EBITDA ratio is currently 0, a key metric in Novartis India Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Novartis India Ltd EV/EBITDA indicates balanced valuation.

Novartis India Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Novartis India Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Novartis India Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Novartis India Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Novartis India Ltd Ratios Analysis Summary

The Novartis India Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Novartis India Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Novartis India Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.